Guardant Health, Inc. (GH)


Guardant Health, Inc. (GH)

$94.64 USD

3.98 (-4.04%)

Updated Aug 23 12:00am

Add GH to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all “A” rated Strong Buy stocks

GH Daily Price Range
GH 52-Week Price Range

GH Stock Chart More Charts


GH Price/Volume Stats

Current price $94.64
Prev. close $98.62
Day low $94.10
Day high $99.43
50-day MA $92.96
200-day MA $66.47
52-week high $112.21
52-week low $27.04
Volume 726,200
Avg. volume 1,010,705
Dividend yield N/A
Market Cap 8.80B

Guardant Health, Inc. (GH) Company Bio


Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.





GH News Stream


Event/Time News Detail
Loading, please wait...

GH Social Stream


Loading social stream, please wait...

View Full GH Social Stream

GH Returns

1-mo -2.40%
3-mo 22.91%
6-mo 72.39%
1-year N/A
3-year N/A
5-year N/A
YTD 151.77%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.3701 seconds.